Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOSTEL IV: nifedipine versus placebo for preterm premature rupture of membranes
2011-000174-66Phase 3Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Preterm prelabor rupture of membranes (PPROM) and Preterm labor (PTL) comparing Nifedipine with Placebo (2 arms). Primary endpoint: Composite neonatal morbidity. Started Feb 2012; status: terminated.
02
Drugs
nifedipine
03
Conditions
Preterm prelabor rupture of membranes (PPROM)Preterm labor (PTL)
Beyond the preview
Go deeper on 2011-000174-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000174-66.